Date: January 7, 2016
In this introductory webinar, we discussed the highlights of pre- and post-market issues, including a discussion of the blurred lines between development of biologics and biosimilars, early-stage regulatory challenges, competitive landscaping, the "patent dance," and more.
This was the first in a series of biosimilars webinars hosted by professionals from Mintz's IP, Health and Litigation sections, covering Patent Prosecution, Health Regulatory, FDA, Patent Litigation, Transactional and Products Liability issues.
Subsequent presentations included:
Part II: FDA/Regulatory — January 28 | 3:00 pm ET
Part III: BPCIA Patent Litigation — February 25 | 3:00 pm ET
Part IV: Transactions and Patent Portfolios — March 17 | 3:00 pm ET
Part V: Post-Market Legal and Regulatory Issues — April 7 | 3:00 pm ET
This webinar series was designed to be valuable to any professional desiring a broad understanding of the biosimilars/biologics industry.